Synthesis and in vitro stability of nucleoside 5'-phosphonate derivatives. 2012

Silvia Vertuani, and Anna Baldisserotto, and Katia Varani, and Pier Andrea Borea, and Bonache De Marcos Maria Cruz, and Luca Ferraro, and Stefano Manfredini, and Alessandro Dalpiaz
Department of Pharmaceutical Sciences, University of Ferrara, via Fossato di Mortara 17-19, 44121 Ferrara, Italy. vrs@unife.it

Nucleoside derivatives are largely synthesized and tested to investigate their influence on platelet aggregation. It's well known that P2Y receptors play an important role in the regulation of platelet function and, as consequence, in controlling atherothrombotic events. The research of compounds that antagonize P2Y(1) and, in particular, P2Y(12) receptors is of great interest in the aim to obtain platelet aggregation inhibitors that are effective in the prevention and treatment of arterial thrombosis. In this study we present the synthesis and in vitro metabolic stability in human blood and rat liver homogenate of a new class of nucleoside derivatives, in particular 5'-phosphonate adenosine, inosine, guanosine and thioadenosine analogues also modified at the ribose moiety. On the basis of the results obtained we can hypothesize compounds 4 and 18 to have in vivo a relatively high stability.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D060326 Chemistry Techniques, Synthetic Methods used for the chemical synthesis of compounds. Included under this heading are laboratory methods used to synthesize a variety of chemicals and drugs. Inorganic Synthesis,Inorganic Synthesis Methods,Inorganic Synthesis Techniques,Methods of Inorganic Synthesis,Methods of Organic Synthesis,Methods of Peptide Synthesis,Organic Synthesis,Organic Synthesis Methods,Organic Synthesis Techniques,Peptide Synthesis Methods,Peptide Synthesis Techniques,Peptide Synthesis, Synthetic,Synthetic Chemistry Techniques,Synthetic Peptide Synthesis,Chemistry Technique, Synthetic,Inorganic Syntheses,Inorganic Synthesis Method,Inorganic Synthesis Technique,Method, Inorganic Synthesis,Method, Organic Synthesis,Method, Peptide Synthesis,Methods, Inorganic Synthesis,Methods, Organic Synthesis,Methods, Peptide Synthesis,Organic Syntheses,Organic Synthesis Technique,Peptide Syntheses, Synthetic,Peptide Synthesis Method,Peptide Synthesis Technique,Syntheses, Inorganic,Syntheses, Organic,Syntheses, Synthetic Peptide,Synthesis Method, Inorganic,Synthesis Method, Peptide,Synthesis Methods, Inorganic,Synthesis Methods, Peptide,Synthesis Technique, Inorganic,Synthesis Technique, Organic,Synthesis Technique, Peptide,Synthesis Techniques, Inorganic,Synthesis Techniques, Organic,Synthesis Techniques, Peptide,Synthesis, Inorganic,Synthesis, Organic,Synthesis, Synthetic Peptide,Synthetic Chemistry Technique,Synthetic Peptide Syntheses,Technique, Inorganic Synthesis,Technique, Organic Synthesis,Technique, Peptide Synthesis,Technique, Synthetic Chemistry,Techniques, Inorganic Synthesis,Techniques, Organic Synthesis,Techniques, Peptide Synthesis,Techniques, Synthetic Chemistry

Related Publications

Silvia Vertuani, and Anna Baldisserotto, and Katia Varani, and Pier Andrea Borea, and Bonache De Marcos Maria Cruz, and Luca Ferraro, and Stefano Manfredini, and Alessandro Dalpiaz
June 2009, Bioorganic & medicinal chemistry letters,
Silvia Vertuani, and Anna Baldisserotto, and Katia Varani, and Pier Andrea Borea, and Bonache De Marcos Maria Cruz, and Luca Ferraro, and Stefano Manfredini, and Alessandro Dalpiaz
August 2003, The Journal of organic chemistry,
Silvia Vertuani, and Anna Baldisserotto, and Katia Varani, and Pier Andrea Borea, and Bonache De Marcos Maria Cruz, and Luca Ferraro, and Stefano Manfredini, and Alessandro Dalpiaz
October 1977, Biokhimiia (Moscow, Russia),
Silvia Vertuani, and Anna Baldisserotto, and Katia Varani, and Pier Andrea Borea, and Bonache De Marcos Maria Cruz, and Luca Ferraro, and Stefano Manfredini, and Alessandro Dalpiaz
January 2005, Nucleosides, nucleotides & nucleic acids,
Silvia Vertuani, and Anna Baldisserotto, and Katia Varani, and Pier Andrea Borea, and Bonache De Marcos Maria Cruz, and Luca Ferraro, and Stefano Manfredini, and Alessandro Dalpiaz
February 2019, Chemistry & biodiversity,
Silvia Vertuani, and Anna Baldisserotto, and Katia Varani, and Pier Andrea Borea, and Bonache De Marcos Maria Cruz, and Luca Ferraro, and Stefano Manfredini, and Alessandro Dalpiaz
September 2014, Chemical reviews,
Silvia Vertuani, and Anna Baldisserotto, and Katia Varani, and Pier Andrea Borea, and Bonache De Marcos Maria Cruz, and Luca Ferraro, and Stefano Manfredini, and Alessandro Dalpiaz
October 1987, Chemical & pharmaceutical bulletin,
Silvia Vertuani, and Anna Baldisserotto, and Katia Varani, and Pier Andrea Borea, and Bonache De Marcos Maria Cruz, and Luca Ferraro, and Stefano Manfredini, and Alessandro Dalpiaz
September 1987, Chemical & pharmaceutical bulletin,
Silvia Vertuani, and Anna Baldisserotto, and Katia Varani, and Pier Andrea Borea, and Bonache De Marcos Maria Cruz, and Luca Ferraro, and Stefano Manfredini, and Alessandro Dalpiaz
January 2000, Nucleic acids symposium series,
Silvia Vertuani, and Anna Baldisserotto, and Katia Varani, and Pier Andrea Borea, and Bonache De Marcos Maria Cruz, and Luca Ferraro, and Stefano Manfredini, and Alessandro Dalpiaz
June 2011, ChemMedChem,
Copied contents to your clipboard!